Hoksch Beatrix, Ablassmaier B, Walter M, Müller J M
Klinik und Poliklinik für Chirurgie, Charité Campus Mitte, Medizinische Fakultät der Humboldt-Universität zu Berlin.
Zentralbl Chir. 2003 Feb;128(2):106-10. doi: 10.1055/s-2003-37763.
To determine whether a thoracoscopic lobectomy used for treatment of primary non-small cell lung cancer shows a higher or lower morbidity in comparison to the conventional resection (thoracotomy) postoperatively.
42 patients with the presumption diagnosis of a lung cancer received a thoracoscopic lobectomy (n=28) or a conventional lobectomy (n=14). Postoperative complication rate (30 days) was analysed prospectively. There were no differences between the groups referring to age, co-morbidity, localisation of the tumor and stage.
Patients with a conventional operation revealed a significant higher morbidity in comparison to the patients of the thoracoscopic group (50 % vs. 14.2 %, p=0.03).
The thoracoscopic lobectomy represents a safe operation method and an alternative to the conventional operation (thoracotomy).
确定与传统切除术（开胸手术）相比，用于治疗原发性非小细胞肺癌的胸腔镜肺叶切除术术后发病率是更高还是更低。
42例疑似肺癌患者接受了胸腔镜肺叶切除术（n = 28）或传统肺叶切除术（n = 14）。前瞻性分析术后并发症发生率（30天）。两组在年龄、合并症、肿瘤位置和分期方面无差异。
与胸腔镜组患者相比，接受传统手术的患者发病率显著更高（50%对14.2%，p = 0.03）。
胸腔镜肺叶切除术是一种安全的手术方法，可替代传统手术（开胸手术）。
